Polysaccharides as drug carriers: Biodisposition of fluorescein-labeled dextrans in mice

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 2, 1997, Pages 181-187

  Kaneo, Yoshiharu ^a   Uemura, Tomochika ^a   Tanaka, Tetsuro ^a   Kanoh, Satoshi ^a  

^a FUKUYAMA UNIVERSITY   (Japan)

Author keywords

biodisposition; fluorescein labeled dextran; high performance size exclusion chromatography; molecular weight; mouse

Indexed keywords

DEXTRAN; DRUG CARRIER; FLUORESCEIN;

ANIMAL EXPERIMENT; ARTICLE; DOSE LIVER FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG FECES LEVEL; DRUG FORMULATION; DRUG UPTAKE; DRUG URINE LEVEL; ISOTOPE LABELING; LIVER CLEARANCE; MALE; MICHAELIS MENTEN KINETICS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PLASMA CLEARANCE;

EID: 0031002529     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.181     Document Type: Article

References (25)

1. Molteni, L., "Drug Carriers in Biology and Medicine," ed. by Gregoriadis G., Academic Press, London, 1979, pp. 107-125.
2. Poznansky M. J., Cleland L. G., "Drug Delivery Systems," ed. by Juliano R. L., Oxford University Press, New York, 1980, pp. 253-315.
3. Mehvar R., Shepard T. L., J. Pharm. Sci., 81, 908-912 (1992).
4. Vansteenkiste S., Schacht E., Duncan R., Seymour L., Pawluczyk I., Baldwin R., J. Controlled Release, 16, 91-100 (1991).
5. Takakura Y., Fujita T., Hashida M., Sezaki, H., Pharm., Res., 7, 339-346 (1990).
6. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
7. Arturson G., Wallenius G., Scand. J. Clin Lab. Invest., 16, 81-86 (1964).
8. Thoren L., Dev. Biol. Stand., 48, 157-167 (1981).
9. Stock R. J., Cilento E. V., McCuskey R. S., Hepatology, 9, 75-82 (1989).
10. Sery T. W., Hehre E. J., J. Bacteriol., 71, 373-380 (1956).
11. Ammon R., Enzymologia, 25, 245-251 (1963).
12. Dahlqvist A., Biochem. J., 86, 72-76 (1963).
13. Rosenfeld E. L., Saienko A. S., Clin. Chim. Acta, 10, 223-228 (1964).
14. Mowry R. W., Millican R. C. Am. J. Pathol., 29, 523-545 (1953).
15. Kaneo Y., Ueno T., Tanaka T., Proceedings, 23rd International Symposium on Controlled Release of Bioactive Materials, Kyoto, July 1996, pp. 101-102.
16. Lake J. R., Licko V., Dyke R. W. V., Scharschmidt B. F., J. Clin. Invest., 76, 676-684 (1985).
17. Scharschmidt B. F., Lake J. R., Renner E. L., Licko V., Dyke R. W. V., Proc. Natl. Acad. Sci. U.S.A., 83, 9488-9492 (1986).
18. Munniksma J., Noteborn M., Kooistra T., Stienstra S., Bouma J. M. W., Gruber M., Brouwer A., Praaning-Vandalen D., Knook D. L., Biochem. J., 192, 613-621 (1980).
19. Watanabe J., Hori K., Iwamoto K., Ozeki S., J. Pharmacobio-Dyn., 8, 468-476 (1985).
20. Watanabe J., Haba M., Muranishi H., Yuasa H., Biol. Pharm. Bull., 16, 1031-1034 (1993).
21. Nishikawa M., Yamashita F., Takakura Y., Hashida M., Sezaki H., J. Pharm. Pharmacol., 44, 396-401 (1992).
22. Groman E. V., Enriquez P. M., Jung C., Josephson L., Bioconjugate Chem., 5, 547-556 (1994).
23. Mehvar R., Reynolds J. M., J. Pharmacol. Exp. Ther., 264, 662-669 (1993).
24. Mehvar R., Reynolds J., J. Pharm. Sci., 83, 1020-1025 (1994).
25. Carpentier J. L., Sawano F., Geiger D., Gorden P., Perrelet A., Orci L., J. Cell. Physiol., 138, 519-526 (1989).